Development of cattle TB vaccines in the UK

Martin Vordermeier*, R. Glyn Hewinson

*Awdur cyfatebol y gwaith hwn

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

13 Dyfyniadau (Scopus)


In 1996, an independent scientific committee chaired by Professor John Krebs, tasked to review the problem of bovine tuberculosis (TB) in GB, concluded that vaccination of cattle offered the best long-term solution for controlling the disease in the National Herd. This view has been re-affirmed recently in the House of Commons Environment, Food and Rural Affairs Committee's report on Bovine TB (2004) and by the findings of the Independent Scientific Group Vaccine Scoping Sub-committee. Significant progress in developing TB vaccines for cattle has been made over the last 5 years. Specifically: (i) DNA or protein subunit vaccines used in combination with BCG have been shown to give superior protection against experimental challenge in cattle than BCG (heterologous prime-boost); (ii) prototype reagents that allow discrimination between vaccinated and infected animals have been developed; and (iii) and correlates of disease severity have been identified that can predict the success or failure of vaccination. These significant advances are detailed in this review with a summary of future directions that TB vaccine development for cattle is likely to take. Crown

Iaith wreiddiolSaesneg
Tudalennau (o-i)38-48
Nifer y tudalennau11
CyfnodolynVeterinary Immunology and Immunopathology
Rhif cyhoeddi1-2
Dyddiad ar-lein cynnar08 Mai 2006
Dynodwyr Gwrthrych Digidol (DOIs)
StatwsCyhoeddwyd - 15 Gorff 2006

Ôl bys

Gweld gwybodaeth am bynciau ymchwil 'Development of cattle TB vaccines in the UK'. Gyda’i gilydd, maen nhw’n ffurfio ôl bys unigryw.

Dyfynnu hyn